Quetiapine Augmentation In Treatment-Resistant Depression – An Open Pilot Study

Mise à jour : Il y a 4 ans
Référence : EUCTR2005-003251-13

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To determine the efficacy of quetiapine in the treatment of depression at 8 weeks, assessed by calculation of the proportion of subjects responding by week 8, derived from the change in Montgomery Asberg Depression Rating Scale (MADRS) score from baseline to week 8.


Critère d'inclusion

  • depression

Liens